Login
Toggle sidebar

Lint: fatty-pancreas-1

Strong List Colon Position
error

"type 1a: preferential fatty replacement of the head, sparing the uncinate process and peribiliary region"

Line 26:8 · When enboldening an intro, the colon should not be bold. '<strong>type 1a:</strong> preferential'

"type 1b: preferential fatty replacement of head, neck, and body, sparing the uncinate process and peribiliary region"

Line 27:8 · When enboldening an intro, the colon should not be bold. '<strong>type 1b:</strong> preferential'

"type 2a: preferential fatty replacement of head, including uncinate process, and sparing the peribiliary region"

Line 28:8 · When enboldening an intro, the colon should not be bold. '<strong>type 2a:</strong> preferential'

"type 2b: total fatty replacement of the pancreas except for the peribiliary region"

Line 29:8 · When enboldening an intro, the colon should not be bold. '<strong>type 2b:</strong> total'
Strong
warning

"Terms such as fatty pancreas, fatty infiltration, pancreatic steatosis and non-alcoholic fatty pancreas (NAFP) tend to be used to indicate abnormal accumulation of interstitial or intracellular fat without significant loss of acinar cells 8,9,25. Non-alcoholic fatty pancreas is associated with obesity and metabolic syndrome."

Line 4:18 · Generally, don't use bold in text: '<strong>fatty pancreas,</strong>'

"Terms such as fatty pancreas, fatty infiltration, pancreatic steatosis and non-alcoholic fatty pancreas (NAFP) tend to be used to indicate abnormal accumulation of interstitial or intracellular fat without significant loss of acinar cells 8,9,25. Non-alcoholic fatty pancreas is associated with obesity and metabolic syndrome."

Line 4:51 · Generally, don't use bold in text: '<strong>fatty infiltration</strong>'

"Terms such as fatty pancreas, fatty infiltration, pancreatic steatosis and non-alcoholic fatty pancreas (NAFP) tend to be used to indicate abnormal accumulation of interstitial or intracellular fat without significant loss of acinar cells 8,9,25. Non-alcoholic fatty pancreas is associated with obesity and metabolic syndrome."

Line 4:88 · Generally, don't use bold in text: '<strong>pancreatic steatosis </strong>'

"Terms such as fatty pancreas, fatty infiltration, pancreatic steatosis and non-alcoholic fatty pancreas (NAFP) tend to be used to indicate abnormal accumulation of interstitial or intracellular fat without significant loss of acinar cells 8,9,25. Non-alcoholic fatty pancreas is associated with obesity and metabolic syndrome."

Line 4:130 · Generally, don't use bold in text: '<strong>non-alcoholic fatty pancreas (NAFP) </strong>'

"Terms such as fatty pancreas, fatty infiltration, pancreatic steatosis and non-alcoholic fatty pancreas (NAFP) tend to be used to indicate abnormal accumulation of interstitial or intracellular fat without significant loss of acinar cells 8,9,25. Non-alcoholic fatty pancreas is associated with obesity and metabolic syndrome."

Line 4:330 · Generally, don't use bold in text: 'Non-alcoholic fatty pancreas<strong> </strong>is associated with obesity and'

"Pancreatic lipomatosis or fatty replacement is more advanced, with replacement of acinar cells."

Line 5:4 · Generally, don't use bold in text: '<strong>Pancreatic lipomatosis </strong>'

"Pancreatic lipomatosis or fatty replacement is more advanced, with replacement of acinar cells."

Line 5:44 · Generally, don't use bold in text: 'or fatty replacement<strong> </strong>is more advanced, with replacement of acinar cells'
Acronyms
warning

"metabolic syndrome, hypertension, dyslipidaemia, obesity and NAFLD"

Line 15:79 · 'NAFLD' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Subtypes"

Line 20:1 · "Subtypes" is not a recognised heading for this article type.
Oxford Comma
suggestion

"metabolic syndrome, hypertension, dyslipidaemia, obesity and NAFLD"

Line 15:49 · Use the Oxford comma in 'dyslipidaemia, obesity and NAFLD'.